Recombinetics, Inc. is a leading company in animal gene editing and related technologies, specializing in biomedical research, regenerative medicine, and animal agriculture. With a team of experienced experts, they develop innovative solutions through their four subsidiaries, focusing on regenerative medicine, precision breeding for healthier and more sustainable farming, and preclinical research for precision medicine in brain tumors.
Recombinetics is dedicated to delivering groundbreaking technology that brings life-changing solutions, such as their biologics for tissue regeneration and their efforts to address the organ shortage crisis through their subsidiary, Makana Therapeutics. Their mission is to improve human health and longevity while adding value to farm animals, ultimately making a positive impact on the world.
Generated from the website